1. R. A. Nash and A. H. Wachter. Pharmaceutical Process
Validation, Marcel Dekkar, Inc., New York, 1993, pp.
17–40.
2. S. Kumar. Quality by Design Approach for
Effervescent Formulation: Product Optimization
Using FbD and Process Validation, Thesis, 2013.
3. Food and Drug Administration. Inspections,
Compliance, Enforcement, and Criminal
Investigations. 2011 [cited 2014 Apr16]; Available
from:
http://www.fda.gov/ICECI/EnforcementActions/W
arningLetters/
4. The European Agency for the Evaluation of
Medicinal Products. Seventh annual report 2001, EU
Commission [cited 2014 Apr 16]; Available from:
http://aei.pitt.edu/49842/1/2001.pdf
5. J. P. Agalloco, and F. J. Carleton. Validation of
Pharmaceutical Processes, CRC Press, 2007.
6. The Global Harmonization Task Force. Quality
Management System-Process Validation Guidance,
GHTF 2004 [cited 2014 Apr 16]; available from:
http://www.fda.gov/OHRMS/DOCKETS/98fr/04d-
0001-bkg0001-10-sg3_n99-10_edition2.pdf
7. World Health Organization. Supplementary
guidelines on good manufacturing practices:
validation, WHO Technical Report Series, No. 937:
2006 [online]. 2006 [cited 2014 Apr 17];Available
from:http://apps.who.int/prequal/info_general/do
cuments/TRS937/WHO_TRS_937-Annex4.pdf.
8. Validation-Online. Design qualification (DQ)
[online]. 2005 [cited 2014 Apr 17]; available from:
http://www.validation-online.net/design
qualification.html.
9. L. Huber. Validation and qualification in analytical
laboratories, New York: Informa Healthcare, 2007.
10. V. B. Patel, M. R. Rathwa, and K. Patel. Studies in
prospective process validation of cimetidine tablet
dosage form, Int J Res Pharm Biomed Sci 2(4),
1823-1826 (2011).
11. S. I. Haider. Validation Standard Operating
Procedures: A Step by Step Guide for Achieving
Compliance in the Pharmaceutical, Medical Device,
and Biotech Industries, CRC Press, 2006.
12. World Health Organization. Quality assurance of
pharmaceuticals: a compendium of guidelines and
related materials. Good manufacturing practices
and inspection, World Health Organization (2):
2007.
13. Process validation guidance [online]. 2007 [cited
2007 Sep 15]; Available from:
http://www.ghtf.Org/sg3/inventorysg3/sg3_fd_n9
9-10_edition2.pdf
14. The Global Harmonization Task Force. Quality
Management System-Process validation guidance
[online]. 2004 [cited 2014 Sep 7]; Available from:
http://www.imdrf.org/docs/ghtf/final/sg3/technic
al-docs/ghtf-sg3-n99-10-2004-qms-processguidance-
04010.pdf.
Ashish Baldi et al., ARPB, 2015; Vol 5 (I) ISSN 2250-0774
(INVITED REVIEW)
824 | P a g e w w w . a r p b . i n f o
15. US Food and Drug Administration. Guidance for
Industry: Process Validation: General Principles and
Practices. U.S. Department of Health and Human
Services, Food and Drug Administration [online].
2011 [cited 2014 Sep 7]; Available from:
http://www.fda.gov/downloads/Drugs/Guidances/
UCM070336.pdf.
16. C. Oechslein and M. Lazar. S-Process Validation from
view report of the FDA, Maas & Peither AG-GMP
Publishing, LOGFILE No. 3, February 2012.
17. Guidelines for Process Validation of
Pharmaceutical Dosage Form-Saudi Food & Drug
Authority, Version 2, 1992.
18. K. Kathiresan, C. Moorthi, Y. Prathyusha, B. R. Gade,
B. K. Reddy and R. Manavalan. An overview of
pharmaceutical validation, Res. J. Pharm. Biol.
Chem. Sci. 1(4):1026-1029 (2010).
19. P. L. Pluta. FDA lifecycle approach to process
validation–What, why, and how, J. Validation
Technol. 17(2): 51-61 (2011).
20. G. A. Lewis, D. Mathieu, and Phan-Tan-LuuRoger,
Pharmaceutical Experimental Design, Marcel
Dekker, Inc, Newyork, 1999.
21. B. Singh, S. Bandyopadhyay, R. Kapil, and N. Ahuja,
Systematic optimization of drug delivery system: An
insight, The Pharma Review: 146-152 (2008).
Thank you for copying data from http://www.arastirmax.com
